BCI Marketplace
Depression Neuromodulation trials

Search for Novel Transcranial Magnetic Stimulation (TMS) Targets for Mental Illness

RecruitingNCT06376734Phase: PHASE2Started 2025-01-30

Summary

Participants will receive Transcranial Magnetic Stimulation (TMS) at a random location in the left prefrontal cortex, excluding sites that are potentially unsafe. Extensive behavioral testing will be conducted to determine which behaviors are modulated by stimulating which circuits.

Eligibility

Sex
ALL
Min Age
18 Years
Max Age
65 Years

Inclusion Criteria: * Age 18-65 * English proficiency sufficient for informed consent, questionnaires/tasks, and treatment * Primary diagnosis of one of the following: major depressive disorder (MDD), obsessive-compulsive disorder (OCD), generalized anxiety disorder (GAD), or schizophrenia (determi

Locations

Acacia Clinics
Sunnyvale, California, United States
Brigham and Women's Hospital
Boston, Massachusetts, United States

Interested in participating? View the full study details on ClinicalTrials.gov:

View on ClinicalTrials.gov →